<a href="https://laohu8.com/S/MMSI">Merit Medical Systems</a> Reports Third-Quarter Revenue of $384.2 Million, Up 13%
Merit Medical Systems Inc. reported revenue of $384.2 million for the third quarter ended September 30, 2025, representing an increase of 13.0% compared to the same period in 2024. Constant currency revenue rose 12.5% year-over-year, while constant currency revenue, organic, increased 7.8%. The company reported a GAAP operating margin of 11.1%, up from 11.0% in the prior year period. Non-GAAP operating margin was 19.7%, compared to 19.2% in the previous year. GAAP earnings per share were $0.46, a decrease of 3.0%. Merit Medical Systems updated its full-year 2025 guidance, raising revenue and non-GAAP earnings per share expectations following the stronger-than-expected third quarter results. The company's President and CEO, Martha G. Aronson, affirmed Merit's commitment to growth initiatives and financial targets through 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merit Medical Systems Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000856982-25-000055), on October 30, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.